Belfast-based Andor Technology has released its first full set of results as a quoted company.
Andor, which makes digital imaging and spectroscopy devices used in scientific research, floated on the AIM market in London last year.
The company said sales in the year to September were £15.7m, up 35%. Pre-tax profits were £850,000, down from £1.2m in the previous year. EBITDA fell 12% to £1.3m. Andor's investment in sales infrastructure pushed up its costs, while it also spent 27% more on research and development.
Andor chairman Bryan Keating said the company was now poised to expand into new sectors, and had identified 'significant long-term growth opportunities' in the space and security sectors. It has already started selling an instrument designed to detect toxic substances.
Sales in Andor's scientific research sector were up 43% and now account for two-thirds of sales. Instrumentation sales grew by 20% to £5m.
